Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Urinary Bladder Neoplasms × Lapatinib × Clear all

Phase

Phase 2 2 Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neoplasm Metastasis 1

Interventions

Positron Emission Tomography Computed Tomography 2 fluciclovine F-18 1 abemaciclib 1 Valproic Acid 1 Tetrahydrouridine 1 Sirolimus 1 Positron-Emission Tomography 1 Oncolytic Virotherapy 1 Magnetic Resonance Imaging 1 Lapatinib 1 Ferrosoferric Oxide 1 Fatty Acids, Omega-3 1 Aminophylline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01245660 2013-01-11

LAPAINBLAD

University Hospital, Bordeaux

Phase EARLY_PHASE1 Terminated

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡